Lipitor 20Mg Tablet
Drug20 mg/day pills.
Other names: atorvastatin
NCT Number: NCT03351998
The purpose of this study is to test how different doses of a statin, Lipitor, affect muscle health and function, and cardiovascular fitness.
Looking for future studies?
Notify Me35 year–65 year
All sexes
Interventional
Phase 4
University of Kansas Medical Center, Kansas City, Kansas, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
20 mg/day pills.
Other names: atorvastatin
80 mg/day pills.
Other names: atorvastatin
Matching placebo pill.
Other names: Placebo
Time frame: value at 12 months minus value at baseline
Time frame: value at 12 months minus value at baseline
University of Kansas Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06080581
Glucose Metabolism Disorders, Hyperinsulinism
Copenhagen, Denmark
View Trial DetailsNCT06080594
Glucose Metabolism Disorders, Hyperinsulinism
Copenhagen, Denmark
View Trial DetailsNCT05958706
Cardiomyopathies, Cardiovascular Diseases
Düsseldorf, Germany
View Trial DetailsNCT06535646
Metabolic Diseases, Mitochondrial Diseases
Sydney, New South Wales, Australia
View Trial Details